Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Haemophilus influenzae type B
Pneumococcal disease
NITAG documentation
2015
2012
Clear all
Type of publications
NITAG documentation
(10)
SAGE documentation
(1)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(22)
Topics
Agenda & Minutes
(1)
Recommendation
(9)
Available to download in languages
English (EN)
(6)
French (FR)
(4)
Regions
Americas
(3)
Europe
(5)
South-East Asia
(1)
Western Pacific
(1)
Countries
Diseases
Haemophilus influenzae type B
(3)
Pneumococcal disease
(7)
Diphtheria
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Human papillomavirus (HPV)
(16)
Influenza
(17)
Measles
(4)
Meningococcal disease
(9)
Pertussis
(4)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(5)
Typhoid
(1)
Varicella
(2)
Yellow fever
(4)
Vaccine topics
Target population
Publication date
2015
(8)
2012
(2)
2024
(4)
2023
(29)
2022
(79)
2021
(165)
2020
(85)
2019
(8)
2018
(13)
2017
(5)
2016
(3)
2014
(6)
2013
(6)
2011
(6)
2010
(12)
2009
(2)
2008
(4)
2007
(2)
2006
(1)
2005
(1)
2004
(2)
2003
(3)
2002
(2)
1997
(1)
1993
(1)
1991
(1)
10 results found
2015
∙
PTAC Immunisation subcommittee
2014-09 immunisation subcommittee minutes
2015
∙
NACI
Re-Immunization with Polysaccharide 23-Valent Pneumococcal Vaccine (Pneu-P-23)
2015
∙
Haut Conseil de la santé publique
Immunisation recommendations for children born prematurely
2015
∙
Conseil Supérieur des Maladies Infectieuses
Immunization against pneumococcal disease in high risk populations or people aged 65 years of age and older
2015
∙
JCVI
JCVI interim statement on adult pneumococcal vaccination
2015
∙
NTAGI
Minutes of the meeting of NTAGI held in 2015
2015
∙
Haut Conseil de la santé publique
Notice relating to the minimum compulsory statements for the publicity of the diphtheria, tetanus, poliomyelitis, pertussis, Haemophilus influenzae b and hepatitis B vaccine Hexyon®
2015
∙
Conseil Supérieur de la Santé (CSS)
Recommendations on Vaccination against Pneumococcus for Children and teenagers
2012
∙
ACIP
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
2012
∙
ACIP
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register